SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-010263
Filing Date
2024-02-06
Accepted
2024-02-06 08:47:33
Documents
1
Group Members
PONTIFAX VI G.P. L.P.RAN NUSSBAUMTOMER KARIV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea192823-13gponti6_nuve.htm SC 13G 102473
  Complete submission text file 0001213900-24-010263.txt   104104
Mailing Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140
Business Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 972-9-9725617
Pontifax Management 4 G.P. (2015) Ltd. (Filed by) CIK: 0001726334 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93555 | Film No.: 24598221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)